Skip to content
MSFT$554.19+35.02(+6.72%)UK Stocks-Factors to watch on November 512:52:05 AM ETMSFT$554.19+35.02(+6.72%)UPDATE 1-Microsoft rejects multibillion-dollar AI deal with UK's Nscale, FT reports12:44:24 AM ETBRK.A$869,300.76+32,855.63(+3.93%)Berkshire Hathaway: The Easy Re-Rating Is Gone12:39:39 AM ETMSFT$554.19+35.02(+6.72%)Microsoft rejects multibillion-dollar AI deal with UK's Nscale, FT reports12:11:41 AM ETMSFT$554.19+35.02(+6.72%)BRIEF-Microsoft Rejects Multibillion-Dollar AI Deal With UK's Nscale - FT12:11:33 AM ETMSFT$554.19+35.02(+6.72%)Microsoft rejects multibillion-dollar AI deal with UK's Nscale, FT reports12:09:40 AM ETTM$205.56+6.45(+3.34%)Toyota profit surges 34%, first rise in six quarters12:02:07 AM ETC$124.58+1.89(+1.54%)UPDATE 1-Oil falls for a fourth day on expectations for lower risk of Iran war escalation11:59:47 PM ETQCOM$160.25+8.76(+5.33%)SpaceX Makes Its Biggest Move Yet Against Telecom Giants With Qualcomm 5G Deal: Elon Musk Hails QCOM's Technology, Calls It 'Excellent'11:59:02 PM ETMCD$278.93+17.15(+6.52%)McDonald's: 3 Key Takeaways for Long-Term Investors11:46:01 PM ETQCOM$160.25+8.76(+5.33%)SpaceX Just Picked Qualcomm for Its Own 5G Network. I Still See the Stock as a Hold.11:41:01 PM ETIONQ$29.52-0.48(-1.60%)IonQ vs. SoundHound AI: Which Technology Stock Is a Better Buy for 2027?11:30:01 PM ETQCOM$160.25+8.76(+5.33%)Qualcomm Q4 Earnings Call Highlights11:27:00 PM ETAMD$485.27+4.95(+1.02%)AMD Stock Jumped After Its Report. I'd Wait for a Lower Price to Buy.11:17:01 PM ETGOOG$288.55+9.01(+3.24%)Google expands voluntary buyouts to 5 countries as AI spending fuels cost cuts11:16:50 PM ETSHOP$153.05+10.32(+7.23%)Shopify: 3 Key Takeaways for Long-Term Investors10:59:40 PM ETMCD$278.93+17.15(+6.52%)Why McDonald's Stock Popped Today10:45:31 PM ETMETA$630.20+8.87(+1.43%)Meta President Says Midterm Results Will Make Building Data Centers Harder10:11:00 PM ETPANW$348.32-2.07(-0.59%)BRIEF-Palo Alto Networks In Talks To Pay $500 Million For AI Security Startup Clutch Security - The Information9:57:31 PM ETMSFT$554.19+35.02(+6.72%)US STOCKS-Wall Street ends higher after Democrats win Congress; data center stocks tumble9:41:58 PM ETASML$1,479.73-72.05(-4.64%)ASML vs. Marvell Technology: Which Artificial Intelligence Stock Is a Better Buy Going into 2027?9:33:56 PM ETABT$115.40+6.10(+5.58%)DIARY-India economic, corporate events on November 59:00:32 PM ETNVO$41.87+1.67(+4.15%)Novo Nordisk: 3 Key Takeaways for Long-Term Investors8:55:55 PM ETAAPL$350.78+17.87(+5.39%)Apple is reportedly cutting budgets for its internal AI usage8:26:22 PM ET

OM · NASDAQ

Outset Medical, Inc.

$4.43 +0.30 (+7.23%)

Company overview

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$83.3M
Employees
354
Headquarters
San Jose, CA
CEO
Leslie L. Trigg
Listed
September 15, 2020
P/E
-1.06
Dividend yield
0.00%

Company financials

Revenue
$118M
Gross profit
$47.8M
Operating income
-$66.9M
EBITDA
-$62.7M
Net income
-$74.8M
EPS
-$4.16
Total assets
$249M
Total debt
$4.7M
Gross margin
40.64%
Net margin
-63.65%
Earnings yield
-93.91%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

2.733.464.194.915.64
OM 1D NASDAQ O4.25H4.49L4.25C4.45+0.30 (+7.23%)Vol94.51K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
OMOutset Medical, Inc. Stock news Outset Medical Q3 Earnings Call Highlights MarketBeat
OMOutset Medical, Inc. Stock news Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates Zacks Investment Research
OMOutset Medical, Inc. Press release Outset Medical Reports Third Quarter 2026 Results GlobeNewswire
OMOutset Medical, Inc. Press release Osisko Metals Closes C$25 Million Flow-Through Share Financing GlobeNewswire
OMOutset Medical, Inc. Press release Osisko Intersects 314 Metres Averaging 0.44% Cu at Gaspé GlobeNewswire
OMOutset Medical, Inc. Press release Outset Medical to Participate in the 2026 Stifel Healthcare Conference GlobeNewswire
OMOutset Medical, Inc. Press release Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026 GlobeNewswire
OMOutset Medical, Inc. Stock news Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock Zacks Investment Research
OMOutset Medical, Inc. Stock news Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript Seeking Alpha
OMOutset Medical, Inc. Stock news Outset Medical Q2 Earnings Call Highlights MarketBeat
OMOutset Medical, Inc. Stock news Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates Zacks Investment Research
OMOutset Medical, Inc. Press release Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 GlobeNewswire
OMOutset Medical, Inc. Press release Osisko Metals Announces Conversion of Glencore Canada's US$25 Million Convertible Debenture GlobeNewswire
OMOutset Medical, Inc. Legal Outset Medical, Inc. (NASDAQ: OM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements, Over $50 Million in Insider Sales PRNewsWire
OMOutset Medical, Inc. Press release Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PRNewsWire
OMOutset Medical, Inc. Press release Osisko Metals Announces Results of Voting at 2026 Annual Meeting of Shareholders and Welcomes Keith McKay to the Board GlobeNewswire
OMOutset Medical, Inc. Press release Outset Medical to Present at RBC Global Healthcare Conference GlobeNewswire
OMOutset Medical, Inc. Stock news Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript Seeking Alpha
OMOutset Medical, Inc. Stock news Outset Medical Q1 Earnings Call Highlights MarketBeat
OMOutset Medical, Inc. Stock news Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates Zacks Investment Research
FAQ

Questions about Outset Medical, Inc.

What does Outset Medical, Inc. do?
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
What is OM's market cap?
Outset Medical, Inc. (OM) is a listed stock with a live quote. The latest market cap on this page is $83.3M.
Where is Outset Medical, Inc. headquartered?
Outset Medical, Inc. is headquartered in San Jose, CA.
How do I get OM news from the API?
Call GET /v1/news?tickers=OM. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does OM news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for OM, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the OM price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.